240 related articles for article (PubMed ID: 12609845)
1. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
[TBL] [Abstract][Full Text] [Related]
2. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
3. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
Nodit L; Bahler DW; Jacobs SA; Locker J; Swerdlow SH
Hum Pathol; 2003 Oct; 34(10):1030-4. PubMed ID: 14608537
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of immunoglobulin variable heavy chain gene mutation status with prognosis in patients with mantle cell lymphoma].
Ji H; Tang Y; He Y; Jiang W; Liao D; Liu W; Li G
Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):90-4. PubMed ID: 25916638
[TBL] [Abstract][Full Text] [Related]
6. Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma.
Wlodarska I; Meeus P; Stul M; Thienpont L; Wouters E; Marcelis L; Demuynck H; Rummens JL; Madoe V; Hagemeijer A
Leukemia; 2004 Oct; 18(10):1705-10. PubMed ID: 15306823
[TBL] [Abstract][Full Text] [Related]
7. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
8. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.
Crespo M; Bosch F; Villamor N; Bellosillo B; Colomer D; Rozman M; Marcé S; López-Guillermo A; Campo E; Montserrat E
N Engl J Med; 2003 May; 348(18):1764-75. PubMed ID: 12724482
[TBL] [Abstract][Full Text] [Related]
9. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
10. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma.
Walsh SH; Thorsélius M; Johnson A; Söderberg O; Jerkeman M; Björck E; Eriksson I; Thunberg U; Landgren O; Ehinger M; Löfvenberg E; Wallman K; Enblad G; Sander B; Porwit-MacDonald A; Dictor M; Olofsson T; Sundström C; Roos G; Rosenquist R
Blood; 2003 May; 101(10):4047-54. PubMed ID: 12637326
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.
Visco C; Hoeller S; Malik JT; Xu-Monette ZY; Wiggins ML; Liu J; Sanger WG; Liu Z; Chang J; Ranheim EA; Gradowski JF; Serrano S; Wang HY; Liu Q; Dave S; Olsen B; Gascoyne RD; Campo E; Swerdlow SH; Chan WC; Tzankov A; Young KH
Am J Surg Pathol; 2011 Feb; 35(2):177-89. PubMed ID: 21263238
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis.
Cuneo A; Rigolin GM; Bigoni R; De Angeli C; Veronese A; Cavazzini F; Bardi A; Roberti MG; Tammiso E; Agostini P; Ciccone M; Della Porta M; Tieghi A; Cavazzini L; Negrini M; Castoldi G
Leukemia; 2004 Mar; 18(3):476-83. PubMed ID: 14712287
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma with t(11;14) and unmutated or mutated VH genes expresses AID and undergoes isotype switch events.
Babbage G; Garand R; Robillard N; Zojer N; Stevenson FK; Sahota SS
Blood; 2004 Apr; 103(7):2795-8. PubMed ID: 14551145
[TBL] [Abstract][Full Text] [Related]
14. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia.
Dewald GW; Brockman SR; Paternoster SF; Bone ND; O'Fallon JR; Allmer C; James CD; Jelinek DF; Tschumper RC; Hanson CA; Pruthi RK; Witzig TE; Call TG; Kay NE
Br J Haematol; 2003 Apr; 121(2):287-95. PubMed ID: 12694251
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma.
Yin CC; Medeiros LJ; Cromwell CC; Mehta AP; Lin P; Luthra R; Abruzzo LV
Mod Pathol; 2007 Jan; 20(1):1-7. PubMed ID: 17057651
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.
Hao S; Sanger W; Onciu M; Lai R; Schlette EJ; Medeiros LJ
Mod Pathol; 2002 Dec; 15(12):1266-72. PubMed ID: 12481006
[TBL] [Abstract][Full Text] [Related]
17. IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL).
Del Giudice I; Davis Z; Matutes E; Osuji N; Parry-Jones N; Morilla A; Brito-Babapulle V; Oscier D; Catovsky D
Leukemia; 2006 Jul; 20(7):1231-7. PubMed ID: 16642047
[TBL] [Abstract][Full Text] [Related]
18. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features.
Navarro A; Clot G; Royo C; Jares P; Hadzidimitriou A; Agathangelidis A; Bikos V; Darzentas N; Papadaki T; Salaverria I; Pinyol M; Puig X; Palomero J; Vegliante MC; Amador V; Martinez-Trillos A; Stefancikova L; Wiestner A; Wilson W; Pott C; Calasanz MJ; Trim N; Erber W; Sander B; Ott G; Rosenwald A; Colomer D; Giné E; Siebert R; Lopez-Guillermo A; Stamatopoulos K; Beà S; Campo E
Cancer Res; 2012 Oct; 72(20):5307-16. PubMed ID: 22915760
[TBL] [Abstract][Full Text] [Related]
19. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression.
Ghia P; Guida G; Stella S; Gottardi D; Geuna M; Strola G; Scielzo C; Caligaris-Cappio F
Blood; 2003 Feb; 101(4):1262-9. PubMed ID: 12406914
[TBL] [Abstract][Full Text] [Related]
20. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.
Camacho FI; Algara P; Rodríguez A; Ruíz-Ballesteros E; Mollejo M; Martínez N; Martínez-Climent JA; González M; Mateo M; Caleo A; Sánchez-Beato M; Menárguez J; García-Conde J; Solé F; Campo E; Piris MA
Blood; 2003 May; 101(10):4042-6. PubMed ID: 12511405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]